Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Iomervu

(iomeprol)

Small molecule

BBracco Diagnostics, Inc

0

Indications

1

Total Trials

0

Active Trials

0

Competitors

2

FDA Applications

NDA/BLA/ANDA regulatory filings

Clinical

Trials by Indication[1]

Age1 trial

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

Completed·GGuerbet·Phase 4·NCT01255722·468 enrolled

Regulatory

FDA Approval Timeline[3]

Nov 27, 2024

IOMERVU

NDA NDA216016

Nov 27, 2024

IOMERVU

NDA NDA216017

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for iomeprol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — iomeprol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
OpenFDA — FDA approval records (NDA NDA216016). U.S. Food & Drug Administration.
[4]
SEC EDGAR — Bracco Diagnostics, Inc company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: BBracco Diagnostics, Inc

Related News